Monthly injection as a future maintenance option
The discussion noted Amgen and Pfizer are working on injectable GLP-1s that could be dosed monthly, representing a potential future direction for maintenance therapy.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.